Detalles de la búsqueda
1.
Phase I, first-in-human trial of programmed cell death receptor-1 (PD-1) inhibitor, JTX-4014, in adult patients with advanced, refractory, solid tumors.
Cancer Immunol Immunother
; 70(3): 763-772, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32989552
2.
Locking Hemodialysis Catheters With Trimethoprim-Ethanol-Ca-EDTA to Prevent Bloodstream Infections: A Randomized, Evaluator-blinded Clinical Trial.
Clin Infect Dis
; 69(1): 130-136, 2019 06 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-30281074
3.
Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study.
J Infect Dis
; 213(10): 1562-72, 2016 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26704612
4.
An open-label, phase 2 trial of RPI.4610 (Angiozyme) in the treatment of metastatic breast cancer.
Cancer
; 118(17): 4098-104, 2012 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22281842
5.
Safety and Immunogenicity of M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR) in Adults.
Vaccines (Basel)
; 9(12)2021 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34960134
6.
An inactivated enterovirus 71 vaccine is safe and immunogenic in healthy adults: A phase I, double blind, randomized, placebo-controlled, study of two dosages.
Vaccine
; 37(31): 4344-4353, 2019 07 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31230881
7.
Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study.
Vaccine
; 33(46): 6351-9, 2015 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-26384447
8.
Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study.
Lancet Infect Dis
; 14(9): 830-8, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25087476
9.
The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men.
J Gerontol A Biol Sci Med Sci
; 68(1): 87-95, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22459616
10.
A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer.
Urol Oncol
; 31(5): 581-8, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21816640
11.
Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers.
J Clin Oncol
; 26(13): 2139-46, 2008 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18390968
Resultados
1 -
11
de 11
1
Próxima >
>>